Bill
Bill > SB426
OK SB426
OK SB426Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.
summary
Introduced
02/03/2025
02/03/2025
In Committee
02/04/2025
02/04/2025
Crossed Over
Passed
Dead
Introduced Session
2025 Regular Session
Bill Summary
An Act relating to the practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties; providing for codification; and providing an effective date.
AI Summary
This bill proposes to designate chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs, which means these medications can be purchased without a prescription from a healthcare provider. Under the proposed law, pharmacists and pharmacies would be prohibited from requiring a prescription for these specific drugs. If the State Board of Pharmacy determines that a pharmacist or pharmacy has violated this requirement, the Board is mandated to take immediate disciplinary action, which includes revoking the professional license and imposing a substantial fine of $100,000 per occurrence. These drugs have gained attention during the COVID-19 pandemic, with some people advocating for their use as potential treatments, though their effectiveness for this purpose remains scientifically controversial. The bill is set to become effective on November 1, 2025, giving pharmacies and healthcare providers advance notice of the upcoming change in drug dispensing regulations.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Coauthored by Senator Sacchieri (on 02/20/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...